Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,543 | 437 | 96.7% |
| Education | $295.81 | 12 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,426 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,192 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $901.95 | 44 | $0 (2024) |
| Mylan Specialty L.P. | $404.78 | 20 | $0 (2024) |
| GENZYME CORPORATION | $399.96 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $391.57 | 22 | $0 (2022) |
| BIOTRONIK INC. | $353.63 | 19 | $0 (2022) |
| Boston Scientific Corporation | $316.84 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $300.89 | 17 | $0 (2023) |
| Amgen Inc. | $267.25 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,840 | 126 | AstraZeneca Pharmaceuticals LP ($778.41) |
| 2023 | $2,970 | 142 | GlaxoSmithKline, LLC. ($696.94) |
| 2022 | $1,611 | 87 | BIOTRONIK INC. ($222.71) |
| 2021 | $1,418 | 94 | Janssen Pharmaceuticals, Inc ($194.04) |
All Payment Transactions
449 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/31/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $26.23 | General |
| Category: Medical Device | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/24/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $81.42 | General |
| Category: PULMONOLOGY | ||||||
| 10/24/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: PULMONOLOGY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.62 | General |
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 600 | 734 | $110,117 | $39,677 |
| 2022 | 4 | 627 | 762 | $147,347 | $48,135 |
| 2021 | 3 | 777 | 975 | $186,422 | $65,989 |
| 2020 | 5 | 665 | 929 | $168,530 | $49,038 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 253 | $52,877 | $19,354 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 250 | $35,500 | $13,675 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,925 | $2,213 | 27.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 97 | 116 | $4,593 | $1,827 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,372 | $1,388 | 41.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 74 | 78 | $5,850 | $1,218 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 512 | 644 | $134,596 | $43,753 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 72 | $10,224 | $3,700 | 36.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 24 | 25 | $1,435 | $508.55 | 35.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 21 | $1,092 | $173.77 | 15.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 528 | 716 | $149,644 | $55,133 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 193 | 199 | $28,258 | $8,565 | 30.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 56 | 60 | $8,520 | $2,291 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 338 | 525 | $109,725 | $30,548 | 27.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 227 | 288 | $40,806 | $13,643 | 33.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 64 | $9,088 | $2,021 | 22.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 35 | $5,635 | $1,715 | 30.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 17 | $3,276 | $1,112 | 33.9% |
About Jasmine Thompson
Jasmine Thompson is a Family healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1013386259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jasmine Thompson has received a total of $8,839 in payments from pharmaceutical and medical device companies, with $2,840 received in 2024. These payments were reported across 449 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($8,543).
As a Medicare-enrolled provider, Thompson has provided services to 2,669 Medicare beneficiaries, totaling 3,400 services with total Medicare billing of $202,839. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Acute Care
- Location Tulsa, OK
- Active Since 09/17/2015
- Last Updated 10/20/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1013386259
Products in Payments
- TRELEGY ELLIPTA (Drug) $913.98
- DUPIXENT (Biological) $681.97
- OFEV (Drug) $543.25
- XARELTO (Drug) $391.57
- YUPELRI (Drug) $381.71
- BEVESPI AEROSPHERE (Drug) $336.10
- ENTRESTO (Drug) $300.89
- BREZTRI (Drug) $298.82
- SPIRIVA RESPIMAT (Drug) $249.24
- NUCALA (Biological) $218.25
- GLASSIA (Biological) $217.13
- WATCHMAN Access System (Device) $200.22
- NEXLETOL (Drug) $192.37
- AIRSUPRA (Drug) $187.71
- ACTHAR (Biological) $187.38
- Repatha (Biological) $180.35
- TYVASO (Drug) $170.49
- FASENRA (Biological) $159.67
- BIOMONITOR (Device) $146.89
- ELIQUIS (Drug) $130.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tulsa
Mr. Jeremy Morgan, Aprn, APRN
Family — Payments: $33,967
Candy Williams, Aprn, Cnp, APRN, CNP
Family — Payments: $14,546
Jillian Oakleaf
Family — Payments: $11,209
Mrs. Erin Rowan, Aprn, APRN
Family — Payments: $11,107
Mr. Lee Matlock, Aprn, APRN
Family — Payments: $11,074
Teresa Donnell, Aprn, APRN
Family — Payments: $9,114